Syn2bio S.A. Stock: price and insider trades · Poland
1 insider bought €31k of shares over the last 90 days, the latest by Maciej Zarębiński, filed 05 Nov 2026.
Syn2bio S.A.: what insiders have been doing
Syn2bio S.A., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to KNF. Over the twelve months to 7 November 2026, 7 filings were filed, from 2 insiders.
Only purchases show up on the open market, 3 purchases in all worth €31k, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Maciej Zarębiński filed the largest purchase, €13k, on 5 November 2026, which represents 0.011% of the company's market value.
The most recent open-market purchase was published on 5 November 2026, 3 days ago. The median gap between a trade and its publication by KNF is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19).
Compared with its exchange (561 companies, median 3 filings), a count of 7 filings is above the norm. The full history, which starts in 2026, counts 3 purchases against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from KNF. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -0.3%Entry PLN 66.80 · Close at T+30 PLN 66.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
- 1,000 shares@ PLN 58.340.011% mcap42.7% of flowShareWSEKNF:node/740983Canonical exit: 1 Feb 2027 (T+90)
- 365 shares@ PLN 56.000.0038% mcap26.7% of flowShareWSEKNF:node/736525Canonical exit: 2 Dec 2026 (T+90)
- 1,000 shares@ PLN 56.000.010% mcap73.3% of flowShareWSEKNF:node/736408Canonical exit: 2 Dec 2026 (T+90)
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
7 of 7 declarations
About Syn2bio S.A.
Syn2bio S.A. is a company specializing in the health and pharmaceutical sector. It is listed on the XWAR market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
